Zimmer Biomet Holdings Inc (ZBH)
121.66
+3.20
(+2.70%)
USD |
NYSE |
May 03, 16:00
121.65
-0.01
(-0.01%)
After-Hours: 20:00
Zimmer Biomet Holdings Cash from Investing (Quarterly): -195.00M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -195.00M |
| December 31, 2023 | -220.80M |
| September 30, 2023 | -165.60M |
| June 30, 2023 | -243.10M |
| March 31, 2023 | -149.40M |
| December 31, 2022 | -112.50M |
| September 30, 2022 | -85.20M |
| June 30, 2022 | -243.20M |
| March 31, 2022 | -88.30M |
| December 31, 2021 | -146.20M |
| September 30, 2021 | -125.20M |
| June 30, 2021 | -109.90M |
| March 31, 2021 | -122.30M |
| December 31, 2020 | -315.90M |
| September 30, 2020 | -91.40M |
| June 30, 2020 | -85.30M |
| March 31, 2020 | -121.20M |
| December 31, 2019 | -138.00M |
| September 30, 2019 | -163.60M |
| June 30, 2019 | -322.20M |
| March 31, 2019 | -105.50M |
| December 31, 2018 | -82.40M |
| September 30, 2018 | -138.90M |
| June 30, 2018 | -93.60M |
| March 31, 2018 | -101.70M |
| Date | Value |
|---|---|
| December 31, 2017 | -128.20M |
| September 30, 2017 | -120.50M |
| June 30, 2017 | -129.00M |
| March 31, 2017 | -133.10M |
| December 31, 2016 | -146.80M |
| September 30, 2016 | -1.374B |
| June 30, 2016 | -266.20M |
| March 31, 2016 | 95.80M |
| December 31, 2015 | 68.70M |
| September 30, 2015 | 94.10M |
| June 30, 2015 | -7.789B |
| March 31, 2015 | 67.90M |
| December 31, 2014 | 28.70M |
| September 30, 2014 | -229.40M |
| June 30, 2014 | -170.30M |
| March 31, 2014 | -98.40M |
| December 31, 2013 | -10.20M |
| September 30, 2013 | -150.70M |
| June 30, 2013 | -174.60M |
| March 31, 2013 | 53.00M |
| December 31, 2012 | -224.60M |
| September 30, 2012 | -85.40M |
| June 30, 2012 | -117.90M |
| March 31, 2012 | -164.20M |
| December 31, 2011 | -213.30M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-322.20M
Minimum
Jun 2019
-85.20M
Maximum
Sep 2022
-162.22M
Average
-142.10M
Median
Cash from Investing (Quarterly) Benchmarks
| Stryker Corp | -408.00M |
| Align Technology Inc | -79.58M |
| Edwards Lifesciences Corp | 63.10M |
| ResMed Inc | -33.15M |
| Globus Medical Inc | 320.62M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 228.00M |
| Cash from Financing (Quarterly) | -50.10M |
| Free Cash Flow | 1.118B |
| Free Cash Flow Per Share (Quarterly) | 0.7779 |
| Free Cash Flow to Equity (Quarterly) | 113.10M |
| Free Cash Flow to Firm (Quarterly) | 201.13M |
| Free Cash Flow Yield | 4.40% |